In antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), pharmacological activation of Nrf2 has been reported to protect endothelial cells and ameliorate glomerulonephritis by inhibiting ROS-induced NETs formation in an AAV mice model [40]. Here, NFE2L2 is linked to glomerulonephritis.